The EMA's Pharmacovigilance Working Party (PhVWP) is recommending an update to the product labelling for rosuvastatin

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1385, 2012-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The EMA's Pharmacovigilance Working Party (PhVWP) has recommended updates to the product labelling of atomoxetine

By  

Reactions Weekly, Vol. 1, Iss. 1384, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The EMA's Pharmacovigilance Working Party (PhVWP) is recommending that labels for proton pump inhibitors (PPIs) be updated

By  

Reactions Weekly, Vol. 1, Iss. 1397, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The EMA's Pharmacovigilance Working Party (PhVWP) recommends that the labelling for all antipsychotics should be updated

By  

Reactions Weekly, Vol. 1, Iss. 1370, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The EMA's Pharmacovigilance Working Party (PhVWP) has concluded a review into the safety of blue dyes

By  

Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

PhVWP July update: camphor and isotretinoin

By  

Reactions Weekly, Vol. 1, Iss. 1313, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite